Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

Cutting through the information clutter in this issue.
A closer look at incretins and Byetta.
Trying out DexCom's continuous glucose monitor.
Drumroll, please.
On June 16, FDA officials provided an update on its safety review of Takeda’s Actos (pioglitazone), announcing that going forward, prescribing information for Actos will...
In previous issues, we’ve documented the arduous journey of Orexigen’s anti-obesity drug Contrave through the regulatory process. In December, an FDA Advisory Committee...
For people with diabetes, driving a car can be dangerous. According to a study of crash data from the United Kingdom, commercial truck drivers with diabetes had a three-...
In June, Insulet announced the acquisition of Neighborhood Diabetes, a medical equipment distributor that specializes in consumer sales of diabetes supplies. The company...
In late June, the European Medicines Agency (EMA) approved Amylin/Eli Lilly/Alkermes’ once-weekly injectable drug Bydureon for type 2 diabetes. We’ve been waiting for...
At the American Diabetes Association’s 71st annual Scientific Sessions held in late June in San Diego, we became excited about a number of therapies in development...

Pages